| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-12 03:24:30 UTC |
|---|
| Updated at | 2022-09-12 03:24:31 UTC |
|---|
| NP-MRD ID | NP0323767 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (1r,3as,3br,4r,9ar,9bs,11s,11ar)-4-(acetyloxy)-9a,11a-dimethyl-7-oxo-1-[(1s)-1-[(1s,3r,5r)-1,5,6,6-tetramethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate |
|---|
| Description | (1S,2R,9R,10R,11S,14R,15R,16S)-9-(acetyloxy)-2,15-dimethyl-5-oxo-14-[(1S)-1-[(1S,3R,5R)-1,5,6,6-tetramethyl-2,7,8-trioxabicyclo[3.2.1]Octan-3-yl]ethyl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]Heptadeca-3,6-dien-16-yl acetate belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. Based on a literature review very few articles have been published on (1S,2R,9R,10R,11S,14R,15R,16S)-9-(acetyloxy)-2,15-dimethyl-5-oxo-14-[(1S)-1-[(1S,3R,5R)-1,5,6,6-tetramethyl-2,7,8-trioxabicyclo[3.2.1]Octan-3-yl]ethyl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]Heptadeca-3,6-dien-16-yl acetate. |
|---|
| Structure | C[C@@H]([C@H]1CC[C@H]2[C@@H]3[C@@H](CC4=CC(=O)C=C[C@]4(C)[C@H]3C[C@H](OC(C)=O)[C@]12C)OC(C)=O)[C@H]1C[C@@]2(C)O[C@](C)(OC2(C)C)O1 InChI=1S/C34H48O8/c1-18(27-17-32(7)30(4,5)41-34(9,40-27)42-32)23-10-11-24-29-25(16-28(33(23,24)8)39-20(3)36)31(6)13-12-22(37)14-21(31)15-26(29)38-19(2)35/h12-14,18,23-29H,10-11,15-17H2,1-9H3/t18-,23+,24-,25-,26+,27+,28-,29-,31-,32+,33+,34-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (1S,2R,9R,10R,11S,14R,15R,16S)-9-(Acetyloxy)-2,15-dimethyl-5-oxo-14-[(1S)-1-[(1S,3R,5R)-1,5,6,6-tetramethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]tetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-16-yl acetic acid | Generator |
|
|---|
| Chemical Formula | C34H48O8 |
|---|
| Average Mass | 584.7500 Da |
|---|
| Monoisotopic Mass | 584.33492 Da |
|---|
| IUPAC Name | (1S,2R,9R,10R,11S,14R,15R,16S)-9-(acetyloxy)-2,15-dimethyl-5-oxo-14-[(1S)-1-[(1S,3R,5R)-1,5,6,6-tetramethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-16-yl acetate |
|---|
| Traditional Name | (1S,2R,9R,10R,11S,14R,15R,16S)-9-(acetyloxy)-2,15-dimethyl-5-oxo-14-[(1S)-1-[(1S,3R,5R)-1,5,6,6-tetramethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-16-yl acetate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | C[C@@H]([C@H]1CC[C@H]2[C@@H]3[C@@H](CC4=CC(=O)C=C[C@]4(C)[C@H]3C[C@H](OC(C)=O)[C@]12C)OC(C)=O)[C@H]1C[C@@]2(C)O[C@](C)(OC2(C)C)O1 |
|---|
| InChI Identifier | InChI=1S/C34H48O8/c1-18(27-17-32(7)30(4,5)41-34(9,40-27)42-32)23-10-11-24-29-25(16-28(33(23,24)8)39-20(3)36)31(6)13-12-22(37)14-21(31)15-26(29)38-19(2)35/h12-14,18,23-29H,10-11,15-17H2,1-9H3/t18-,23+,24-,25-,26+,27+,28-,29-,31-,32+,33+,34-/m0/s1 |
|---|
| InChI Key | RLGUIWFPPDEEKG-WOSGGNHHSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Pregnane steroids |
|---|
| Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Progestogin-skeleton
- Steroid ester
- 3-oxo-delta-1,4-steroid
- 3-oxosteroid
- Oxosteroid
- Delta-1,4-steroid
- 1,3-dioxepane
- Carboxylic acid orthoester
- Dioxepane
- Ortho ester
- Dicarboxylic acid or derivatives
- Meta-dioxane
- Meta-dioxolane
- Ketone
- Carboxylic acid ester
- Orthocarboxylic acid derivative
- Cyclic ketone
- Organoheterocyclic compound
- Carboxylic acid derivative
- Oxacycle
- Organooxygen compound
- Organic oxygen compound
- Organic oxide
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|